Trade now with Barclays Stockbrokers
14-Mar-24 |
Buy |
Mark Radcliffe |
0.000p | 5,354,015 |
£0.00 |
20-Dec-23 |
Sell |
Daniel Barton |
97.57p | 104,102 |
£101,567.64 |
20-Dec-23 |
Exercise of option |
Daniel Barton |
0.000p | 220,869 |
£0.00 |
06-Jul-23 |
Sell |
Philip Bowcock |
71.30p | 185,000 |
£131,905.00 |
06-Jul-23 |
Sell |
Philip Bowcock |
71.30p | 185,000 |
£131,905.00 |
20-Dec-23 |
Sell |
Daniel Barton |
97.57p | 104,102 |
£101,567.64 |
14-Mar-24 |
Buy |
Mark Radcliffe |
0.000p | 5,354,015 |
£0.00 |
20-Dec-23 |
Exercise of option |
Daniel Barton |
0.000p | 220,869 |
£0.00 |
Mark Radcliffe |
158,433,657 |
£152,413,178 |
Philip Bowcock |
1,259,718 |
£1,211,849 |
Daniel Barton |
55,490 |
£53,381 |
Damian Sanders |
25,933 |
£24,948 |
Dianne Walker |
22,154 |
£21,312 |
Neil Radcliffe |
35,592,130 |
£34,239,629 |
Kayne Anderson Rudnick Investment Management LLC |
12,914,138 |
£12,423,401 |
Martin Stewart |
10,708,031 |
£10,301,126 |
|
Final |
Final |
Ex-Div |
18-Jul-24 |
08-Feb-24 |
Paid |
16-Aug-24 |
08-Mar-24 |
Amount |
0.52p |
0.95p |
08:25 |
35,000 @ 97.00p |
08:24 |
3,303 @ 97.00p |
08:24 |
80,000 @ 97.00p |
08:23 |
175,000 @ 97.00p |
08:22 |
2,596 @ 97.00p |
Chair |
Philip Bowcock |
CEO |
Mark Radcliffe |
CFO |
Daniel Barton |
Top of Page
You are here:
research